TNFRSF12A and neoplasm: Targeting Fn14 with antibody 002 was able to prevent increased 18F‐FDG uptake in C26 tumours, but more importantly, tumours of cachectic C26 mice with high 18F‐FDG uptake showed reduced 18F‐FDG after 2 days of therapy with 002.